{"id":"https://openalex.org/W2087994656","doi":"https://doi.org/10.2174/187152009789056958","title":"WT1 Peptide Vaccine as a Paradigm for \u201cCancer Antigen-Derived Peptide\u201d-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide","display_name":"WT1 Peptide Vaccine as a Paradigm for \u201cCancer Antigen-Derived Peptide\u201d-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide","publication_year":2009,"publication_date":"2009-09-01","ids":{"openalex":"https://openalex.org/W2087994656","doi":"https://doi.org/10.2174/187152009789056958","mag":"2087994656","pmid":"https://pubmed.ncbi.nlm.nih.gov/19538172"},"language":"en","primary_location":{"id":"doi:10.2174/187152009789056958","doi":"https://doi.org/10.2174/187152009789056958","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152009789056958","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101956353","display_name":"Yoshitaka Oka","orcid":"https://orcid.org/0000-0002-3482-3051","observed_orcids":["https://orcid.org/0000-0002-3482-3051"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiro Oka","raw_affiliation_strings":["Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan. yoshi@imed3.med.osaka-u.ac.jp","Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan. yoshi@imed3.med.osaka-u.ac.jp","institution_ids":["https://openalex.org/I98285908"]},{"raw_affiliation_string":"Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011392452","display_name":"Akihiro Tsuboi","orcid":"https://orcid.org/0000-0003-3182-2456","observed_orcids":["https://orcid.org/0000-0003-3182-2456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akihiro Tsuboi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030032184","display_name":"Fumihiro Fujiki","orcid":"https://orcid.org/0000-0002-2433-510X","observed_orcids":["https://orcid.org/0000-0002-2433-510X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fumihiro Fujiki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101426730","display_name":"Zheyu Li","orcid":"https://orcid.org/0009-0008-4952-8523","observed_orcids":["https://orcid.org/0009-0008-4952-8523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zheyu Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101521134","display_name":"Hiroko Nakajima","orcid":"https://orcid.org/0000-0003-1686-8819","observed_orcids":["https://orcid.org/0000-0003-1686-8819"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroko Nakajima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058809000","display_name":"Naoki Hosen","orcid":"https://orcid.org/0000-0001-9570-0947","observed_orcids":["https://orcid.org/0000-0001-9570-0947"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoki Hosen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000288432","display_name":"Toshiaki Shirakata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshiaki Shirakata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004685668","display_name":"Sumiyuki Nishida","orcid":"https://orcid.org/0000-0003-0137-8649","observed_orcids":["https://orcid.org/0000-0003-0137-8649"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sumiyuki Nishida","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038214190","display_name":"Yusuke Oji","orcid":"https://orcid.org/0000-0002-2935-1184","observed_orcids":["https://orcid.org/0000-0002-2935-1184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yusuke Oji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112166099","display_name":"Ichiro Kawase","orcid":"https://orcid.org/0000-0001-8166-9360","observed_orcids":["https://orcid.org/0000-0001-8166-9360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ichiro Kawase","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021069937","display_name":"Haruo Sugiyama","orcid":"https://orcid.org/0000-0002-0844-2175","observed_orcids":["https://orcid.org/0000-0002-0844-2175"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Haruo Sugiyama","raw_affiliation_strings":["Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, 2-2, Yamada-Oka, Suita City, Osaka 565-0871, Japan., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, 2-2, Yamada-Oka, Suita City, Osaka 565-0871, Japan., Japan","institution_ids":["https://openalex.org/I98285908"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021069937"],"corresponding_institution_ids":["https://openalex.org/I98285908"],"apc_list":null,"apc_paid":null,"fwci":1.5159,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.82067732,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"9","issue":"7","first_page":"787","last_page":"797"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/wt1-peptide-vaccine","display_name":"WT1 peptide vaccine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/wilms-tumor-1","display_name":"Wilms tumor 1","score":0.8159999847412109},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8389999866485596},{"id":"https://openalex.org/keywords/peptide-vaccination","display_name":"peptide vaccination","score":0.42800000309944153},{"id":"https://openalex.org/keywords/delayed-type-hypersensitivity","display_name":"delayed-type hypersensitivity","score":0.9470000267028809},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.5680000185966492},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pediatric-malignancies","display_name":"pediatric malignancies","score":0.8859999775886536},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.75},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9639999866485596},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6191657185554504},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6161753535270691},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5852738618850708},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5744315981864929},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.569186270236969},{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.5675258636474609},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5500154495239258},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5326017737388611},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.46224546432495117},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4490169882774353},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.42769455909729004},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.4157719016075134},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18289580941200256},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.15752851963043213}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D025721","descriptor_name":"WT1 Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/187152009789056958","doi":"https://doi.org/10.2174/187152009789056958","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152009789056958","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:19538172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19538172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer agents in medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2416869537","https://openalex.org/W2036635542","https://openalex.org/W1972526027","https://openalex.org/W2160433006","https://openalex.org/W2024407708","https://openalex.org/W2003306132","https://openalex.org/W2765431425","https://openalex.org/W2161872048","https://openalex.org/W1185746224","https://openalex.org/W2118120713"],"abstract_inverted_index":{"Wilms'":[0],"tumor":[1,108],"gene":[2],"(WT1)":[3],"possesses":[4],"oncogenic":[5],"functions":[6],"and":[7,59,84,115],"is":[8,142,194],"expressed":[9],"in":[10,44,85,112,200,223,241],"various":[11],"kinds":[12],"of":[13,27,61,117,123,128,134,150,175,177,181,203,208,239],"malignancies,":[14],"which":[15,72,130],"suggests":[16],"that":[17,49,144,165],"the":[18,21,28,35,81,90,166,178,201],"gene's":[19],"product,":[20],"WT1":[22,36,47,66,151,167,192,214,220],"protein,":[23],"should":[24,227],"be":[25,41,132,228],"one":[26],"most":[29],"promising":[30,231],"cancer":[31,45,62,135,182],"antigens.":[32],"In":[33],"fact,":[34],"protein":[37],"was":[38,138],"shown":[39],"to":[40,102,159,233],"highly":[42],"immunogenic":[43],"patients.":[46],"peptides":[48,68],"could":[50],"induce":[51,160],"WT1-specific":[52],"CTLs":[53],"(WT1":[54],"CTL":[55,67],"peptides)":[56],"were":[57,73],"identified,":[58],"vaccination":[60,193,222],"patients":[63,183],"with":[64,125,146,191,243],"these":[65],"induced":[69,97],"immunological":[70,98,155],"responses,":[71],"assessed":[74],"by":[75],"ex":[76],"vivo":[77,86],"immuno-monitoring,":[78,87],"such":[79,88,105],"as":[80,89,106],"tetramer":[82],"assay,":[83],"peptide-specific":[91],"delayed":[92],"type":[93],"hypersensitivity":[94],"reaction.":[95],"The":[96,173],"responses":[99,104],"then":[100],"led":[101],"clinical":[103,162],"solid":[107],"shrinkage,":[109],"a":[110,147,161,230],"decrease":[111],"leukemia":[113],"cells,":[114],"reduction":[116],"M-protein":[118],"(multiple":[119],"myeloma).":[120],"Long-term":[121],"stabilization":[122],"disease":[124],"good":[126],"quality":[127],"life,":[129],"might":[131],"characteristic":[133],"vaccine":[136,169],"therapy,":[137,204],"also":[139,188],"reported.":[140],"It":[141],"noteworthy":[143],"injection":[145],"\"single\"":[148],"kind":[149],"peptide":[152,168,221],"elicited":[153],"an":[154,224],"response":[156],"strong":[157],"enough":[158],"response,":[163],"indicating":[164],"has":[170],"therapeutic":[171],"potential.":[172],"number":[174],"reports":[176],"successful":[179],"treatment":[180,232],"(not":[184],"only":[185],"adult":[186],"but":[187],"childhood":[189],"malignancies)":[190],"increasing.":[195],"Strategies":[196],"for":[197],"further":[198],"improvement":[199],"efficacy":[202],"including":[205],"combined":[206],"use":[207],"chemotherapy":[209],"drugs,":[210,212],"molecular-target-based":[211],"or":[213,237],"helper":[215],"peptides,":[216],"are":[217],"being":[218],"proposed.":[219],"\"adjuvant":[225],"setting\"":[226],"considered":[229],"protect":[234],"against":[235],"progression":[236],"relapse":[238],"malignancies":[240],"cases":[242],"minimal":[244],"residual":[245],"disease.":[246]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}